<?xml version="1.0" encoding="utf-8"?>
<iati-activities version="2.03" generated-datetime="2026-11-11T15:32:23+00:00">
  <iati-activity last-updated-datetime="2026-11-11T11:05:58+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-RWA-C-MOH-1</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Supporting Rwanda Towards Reducing TB and HIV-related Morbidity and Mortality - Rwanda (01-Jul-2021-30-Jun-2024)</narrative>
    </title>
    <description type="1">
      <narrative>Rwanda, TB/HIV, Ministry of Health of the Republic of Rwanda</narrative>
    </description>
    <description type="2">
      <narrative>Goals: New HIV infections are reduced by 2024; HIV related deaths and comorbidities are reduced and HIV morbidity is decreased; People infected and affected by HIV have the same opportunities as the general population; 57% reduction in TB deaths (compared with 2015) by 2024; 35% reduction in TB incidence rate (compared with 2015) by 2024; TBD affected families facing catastrophic costs due to tuberculosis. Objectives: To enhance surveillance at community, ports of entry and at health facilities; To improve sample collection and referral mechanisms, and laboratory testing/diagnostic capacities; To improve infection prevention &amp; control for COVID-19 in all health facilities; To improve clinical capacities of hospitals to manage COVID-19 cases; People infected and affected by HIV and  MVC have improved socio-economic status and protection; SGBV and HIV related stigma and discrimination are reduced; Considering the Patient Pathway for Tuberculosis; Targeted approaches for key drivers of TB epidemic and selected populations; Programme management, multi-Sectoral collaboration &amp; engaging all care providers; Universal Health Coverage, social protection, human rights &amp; gender, nutrition; Stable and quality assured supply of drugs, diagnostics and commodities; M&amp;E and data quality system (e-TB, health information system, Civil registration and vital statistics (CRVS) system.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="10" role="2" crs-channel-code="12001">
      <narrative>Ministry of Health of the Republic of Rwanda</narrative>
    </participating-org>
    <participating-org type="10" role="4" crs-channel-code="12001">
      <narrative>Ministry of Health of the Republic of Rwanda</narrative>
    </participating-org>
    <other-identifier ref="RWA-C-MOHP01" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="3" />
    <activity-date type="1" iso-date="2021-07-01" />
    <activity-date type="2" iso-date="2021-07-01" />
    <activity-date type="3" iso-date="2024-06-30" />
    <activity-date type="4" iso-date="2024-06-30" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Musoke Sempala</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>musoke.sempala@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="RW" percentage="100">
      <narrative>Rwanda</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12110" percentage="100">
      <narrative>Multicomponent</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="5c677774-886d-4d23-a93a-04db303b23e6" percentage="100">
        <description>
          <narrative>Multicomponent -&gt; Payment for results -&gt; Payment for results</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2021-01-01" />
      <period-end iso-date="2021-12-31" />
      <value currency="USD" value-date="2021-01-01">47986878.92</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2022-01-01" />
      <period-end iso-date="2022-12-31" />
      <value currency="USD" value-date="2022-01-01">62322358.26</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2023-01-01" />
      <period-end iso-date="2023-12-31" />
      <value currency="USD" value-date="2023-01-01">56469879.96</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2024-01-01" />
      <period-end iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-01-01">56545980.89</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2025-01-01" />
      <period-end iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-01-01">18122656.41</value>
    </budget>
    <capital-spend percentage="22.37" />
    <transaction ref="0c22e43c-675f-4d0e-a757-897cdf5fa904">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-08-10" />
      <value currency="USD" value-date="2021-08-10">81042006.29</value>
      <description>
        <narrative>Global Fund commitment to RWA-C-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7ca51994-9bb4-4b77-8275-8fb68b07f9e2">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-08-12" />
      <value currency="USD" value-date="2021-08-12">21686063.48</value>
      <description>
        <narrative>Global Fund disbursement to RWA-C-MOHP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e22669d2-b389-44fa-ad15-5ad599b1c9b2">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-09-14" />
      <value currency="USD" value-date="2021-09-14">2839561.45</value>
      <description>
        <narrative>Global Fund commitment to RWA-C-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d2e2b1bd-6036-483e-85ec-287408c60f4f">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-09-16" />
      <value currency="USD" value-date="2021-09-16">8523338.00</value>
      <description>
        <narrative>Global Fund disbursement to RWA-C-MOHP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="60ddf968-2d05-4d84-ad9c-95e45f200b13">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-09-17" />
      <value currency="USD" value-date="2021-09-17">-2839561.45</value>
      <description>
        <narrative>Global Fund commitment to RWA-C-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="38da0643-3925-452d-beaa-9dc987f5efdf">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-09-17" />
      <value currency="USD" value-date="2021-09-17">3386053.30</value>
      <description>
        <narrative>Global Fund commitment to RWA-C-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="dee683c6-7c07-48e9-9f80-9892587bc11d">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-10-01" />
      <value currency="USD" value-date="2021-10-01">412479.11</value>
      <description>
        <narrative>Global Fund disbursement to RWA-C-MOHP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="f0278ab1-bb8e-4465-90e9-a7a82f966a79">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-10-05" />
      <value currency="USD" value-date="2021-10-05">12543144.34</value>
      <description>
        <narrative>Global Fund disbursement to RWA-C-MOHP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0c87ff96-7148-445c-853b-a8a8fb634f31">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-10-08" />
      <value currency="USD" value-date="2021-10-08">-2973574.19</value>
      <description>
        <narrative>Global Fund commitment to RWA-C-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6417267a-5335-484b-afe5-2dfdd21a1ec9">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-10-08" />
      <value currency="USD" value-date="2021-10-08">-412479.11</value>
      <description>
        <narrative>Global Fund commitment to RWA-C-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e5e63a11-94dd-4253-b0b8-be046b31878e">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-10-08" />
      <value currency="USD" value-date="2021-10-08">3386053.30</value>
      <description>
        <narrative>Global Fund commitment to RWA-C-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="309e7197-32ed-49ab-bc80-2ae625fda2cd">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-10-08" />
      <value currency="USD" value-date="2021-10-08">-3386053.30</value>
      <description>
        <narrative>Global Fund commitment to RWA-C-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="935d6cc2-ef04-4d9a-83c5-2a2d2e1d74f3">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-10-08" />
      <value currency="USD" value-date="2021-10-08">3386053.30</value>
      <description>
        <narrative>Global Fund commitment to RWA-C-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6aab9ed0-8d37-46e3-9dab-942c23c43f2e">
      <transaction-type code="7" />
      <transaction-date iso-date="2021-10-19" />
      <value currency="USD" value-date="2021-10-19">412479.11</value>
      <description>
        <narrative>Funds returned to the Global Fund from RWA-C-MOHP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8956d422-7b90-425e-a33e-973bef30e169">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-10-19" />
      <value currency="USD" value-date="2021-10-19">412479.11</value>
      <description>
        <narrative>Global Fund disbursement to RWA-C-MOHP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="36ac8213-aa79-4459-8cea-94311dc0b449">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-11-05" />
      <value currency="USD" value-date="2021-11-05">-2973574.19</value>
      <description>
        <narrative>Global Fund commitment to RWA-C-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3871c1c9-1d96-4fe5-bcbf-508f300cd9aa">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-11-05" />
      <value currency="USD" value-date="2021-11-05">3165770.96</value>
      <description>
        <narrative>Global Fund commitment to RWA-C-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="604f5cc2-e7be-41a1-860b-770cb41e24a8">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-11-06" />
      <value currency="USD" value-date="2021-11-06">3531049.20</value>
      <description>
        <narrative>Global Fund commitment to RWA-C-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="304c7d44-8c16-4d0a-adbe-203ccf6f4229">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-11-06" />
      <value currency="USD" value-date="2021-11-06">-3165770.96</value>
      <description>
        <narrative>Global Fund commitment to RWA-C-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2fc5bbdf-7143-44a9-8397-dc6451346558">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-11-08" />
      <value currency="USD" value-date="2021-11-08">999416.71</value>
      <description>
        <narrative>Global Fund disbursement to RWA-C-MOHP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="8455651d-4d60-47d3-9f78-f3a345ba70b8">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-11-09" />
      <value currency="USD" value-date="2021-11-09">184551.15</value>
      <description>
        <narrative>Global Fund disbursement to RWA-C-MOHP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="c6e42fc4-340b-4319-8abf-58fe4b61db04">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-11-09" />
      <value currency="USD" value-date="2021-11-09">1154844.52</value>
      <description>
        <narrative>Global Fund disbursement to RWA-C-MOHP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="b7f9727d-918f-456d-9000-b96e49059a32">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-11-17" />
      <value currency="USD" value-date="2021-11-17">521018.42</value>
      <description>
        <narrative>Global Fund disbursement to RWA-C-MOHP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="a735c606-16e0-4412-90d3-b5112cdef819">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-11-22" />
      <value currency="USD" value-date="2021-11-22">-38289460.47</value>
      <description>
        <narrative>Global Fund commitment to RWA-C-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="cce9d699-66c4-40f8-b14c-660401185e1c">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-11-22" />
      <value currency="USD" value-date="2021-11-22">68102779.47</value>
      <description>
        <narrative>Global Fund commitment to RWA-C-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4ebd4208-62ff-47bc-88f6-2e79ef6fb826">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-11-25" />
      <value currency="USD" value-date="2021-11-25">13357472.00</value>
      <description>
        <narrative>Global Fund disbursement to RWA-C-MOHP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="74ee696c-889d-4966-ab18-2fa90f0935dd">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-12-08" />
      <value currency="USD" value-date="2021-12-08">663140.22</value>
      <description>
        <narrative>Global Fund commitment to RWA-C-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a6f80911-ec00-4925-b158-1aeb46b6212a">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-12-08" />
      <value currency="USD" value-date="2021-12-08">-671218.40</value>
      <description>
        <narrative>Global Fund commitment to RWA-C-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="124f5d39-c3e9-4346-9cab-0d5c9ac47e29">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-12-10" />
      <value currency="USD" value-date="2021-12-10">57918.71</value>
      <description>
        <narrative>Global Fund disbursement to RWA-C-MOHP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="d05d6046-a98d-4a55-9e2c-2490736f4a0e">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-01-20" />
      <value currency="USD" value-date="2022-01-20">7595058.42</value>
      <description>
        <narrative>Global Fund disbursement to RWA-C-MOHP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a3b9db86-65be-455b-a2fe-aebf96817185">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-01-20" />
      <value currency="USD" value-date="2022-01-20">261657.00</value>
      <description>
        <narrative>Global Fund disbursement to RWA-C-MOHP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="f8d881c9-c681-4b16-9ebc-f181a1bed383">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-01-30" />
      <value currency="USD" value-date="2022-01-30">-315977.62</value>
      <description>
        <narrative>Global Fund commitment to RWA-C-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="353e7003-b163-4c08-9525-6fb9ae2dd068">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-01-30" />
      <value currency="USD" value-date="2022-01-30">235785.84</value>
      <description>
        <narrative>Global Fund commitment to RWA-C-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b6b27d9b-9cd4-4bf6-b766-bdeb46033727">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-02-01" />
      <value currency="USD" value-date="2022-02-01">289243.89</value>
      <description>
        <narrative>Global Fund disbursement to RWA-C-MOHP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="f2b1f1e0-d15c-4a54-99bf-50a0ce35d56f">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-02-13" />
      <value currency="USD" value-date="2022-02-13">209579.05</value>
      <description>
        <narrative>Global Fund commitment to RWA-C-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3bd80004-c830-43d4-96a6-5fd7057a52fd">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-02-13" />
      <value currency="USD" value-date="2022-02-13">-235785.84</value>
      <description>
        <narrative>Global Fund commitment to RWA-C-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4f822d06-d5af-4ee9-a24f-2ce056ab96da">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-03-10" />
      <value currency="USD" value-date="2022-03-10">-98942.88</value>
      <description>
        <narrative>Global Fund commitment to RWA-C-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="103daf4d-7896-469b-b1c6-224ed0632e54">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-03-10" />
      <value currency="USD" value-date="2022-03-10">308521.93</value>
      <description>
        <narrative>Global Fund commitment to RWA-C-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="18076d1d-2449-4a76-a7bd-ec248b59bd24">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-03-10" />
      <value currency="USD" value-date="2022-03-10">-209579.05</value>
      <description>
        <narrative>Global Fund commitment to RWA-C-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="08cc9638-56cb-4408-bd64-e2c939694dff">
      <transaction-type code="7" />
      <transaction-date iso-date="2022-03-15" />
      <value currency="USD" value-date="2022-03-15">98942.88</value>
      <description>
        <narrative>Funds returned to the Global Fund from RWA-C-MOHP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f138bc8e-4b3a-4837-ba87-91e79c814db0">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-04-07" />
      <value currency="USD" value-date="2022-04-07">540098.00</value>
      <description>
        <narrative>Global Fund disbursement to RWA-C-MOHP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a7ea72cd-0476-4b80-b0fc-2e7b43eca5ba">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-04-07" />
      <value currency="USD" value-date="2022-04-07">9013127.59</value>
      <description>
        <narrative>Global Fund disbursement to RWA-C-MOHP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d0a2a6a2-92f3-4747-864f-1ddf3a8a991b">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-04-18" />
      <value currency="USD" value-date="2022-04-18">-308521.93</value>
      <description>
        <narrative>Global Fund commitment to RWA-C-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5ddd08dc-4578-4701-8970-11582a0b96bd">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-04-18" />
      <value currency="USD" value-date="2022-04-18">133544.70</value>
      <description>
        <narrative>Global Fund commitment to RWA-C-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f980876d-2306-49d7-a37c-51ff506eaff1">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-05-18" />
      <value currency="USD" value-date="2022-05-18">130490.35</value>
      <description>
        <narrative>Global Fund disbursement to RWA-C-MOHP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="b163575f-c7a0-45e5-8924-a81f803b4424">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-07-01" />
      <value currency="USD" value-date="2022-07-01">6855637.00</value>
      <description>
        <narrative>Global Fund disbursement to RWA-C-MOHP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="647f2a4b-5b35-48ca-9125-3a521b6fdf30">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-07-01" />
      <value currency="USD" value-date="2022-07-01">17499053.21</value>
      <description>
        <narrative>Global Fund disbursement to RWA-C-MOHP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="5b6a8144-6b1a-45a4-bf22-c8502e996317">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-07-13" />
      <value currency="USD" value-date="2022-07-13">-3054.35</value>
      <description>
        <narrative>Global Fund commitment to RWA-C-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f31efea2-0efe-4020-b45e-5176bf07e272">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-10-06" />
      <value currency="USD" value-date="2022-10-06">12705559.25</value>
      <description>
        <narrative>Global Fund disbursement to RWA-C-MOHP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="2efbe51e-9004-49d7-92b4-5a42943d9dcd">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-10-06" />
      <value currency="USD" value-date="2022-10-06">275117.00</value>
      <description>
        <narrative>Global Fund disbursement to RWA-C-MOHP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="aad543e3-9acc-4ec9-962e-e663c874c294">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-04-07" />
      <value currency="USD" value-date="2023-04-07">71006246.00</value>
      <description>
        <narrative>Global Fund commitment to RWA-C-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="11aca048-7ca3-4b94-a03d-32a6328e54c2">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-04-13" />
      <value currency="USD" value-date="2023-04-13">6545174.00</value>
      <description>
        <narrative>Global Fund disbursement to RWA-C-MOHP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="22c516f2-6bc1-4381-9d0c-da0b7e3390e1">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-04-13" />
      <value currency="USD" value-date="2023-04-13">21987900.00</value>
      <description>
        <narrative>Global Fund disbursement to RWA-C-MOHP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ec2236ce-7e4d-429e-a190-320ab24c2939">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-07-18" />
      <value currency="USD" value-date="2023-07-18">13464098.00</value>
      <description>
        <narrative>Global Fund disbursement to RWA-C-MOHP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0412c84e-792c-4fd9-9e9d-663454de10e7">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-07-23" />
      <value currency="USD" value-date="2023-07-23">25000.00</value>
      <description>
        <narrative>Global Fund commitment to RWA-C-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4ceb6a91-b3cf-44c1-89fb-2bf8def098a1">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-08-31" />
      <value currency="USD" value-date="2023-08-31">25000.00</value>
      <description>
        <narrative>Global Fund disbursement to RWA-C-MOHP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="3980971a-ddd0-40d2-80b1-51b3135febab">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-09-12" />
      <value currency="USD" value-date="2023-09-12">6122665.15</value>
      <description>
        <narrative>Global Fund disbursement to RWA-C-MOHP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="48d0fde6-36de-443f-af9b-a28fcee47913">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-10-26" />
      <value currency="USD" value-date="2023-10-26">12111190.00</value>
      <description>
        <narrative>Global Fund disbursement to RWA-C-MOHP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="682dfb30-e296-465c-b911-bd874754a7e0">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-12-13" />
      <value currency="USD" value-date="2023-12-13">408926.15</value>
      <description>
        <narrative>Global Fund commitment to RWA-C-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e25f1b6a-edc8-4bb5-9345-05eb2f882ed7">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-01-09" />
      <value currency="USD" value-date="2024-01-09">51091.50</value>
      <description>
        <narrative>Global Fund commitment to RWA-C-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b8b6806e-0609-45f2-8857-f8aa32e91343">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-01-26" />
      <value currency="USD" value-date="2024-01-26">19534810.79</value>
      <description>
        <narrative>Global Fund commitment to RWA-C-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="35fed696-1e61-4b24-b28d-eb8dd1297069">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-01-26" />
      <value currency="USD" value-date="2024-01-26">-10775218.85</value>
      <description>
        <narrative>Global Fund commitment to RWA-C-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c3b77cc7-3325-4036-830a-a4a0a1418ea4">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-01-30" />
      <value currency="USD" value-date="2024-01-30">6009091.00</value>
      <description>
        <narrative>Global Fund disbursement to RWA-C-MOHP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="84fc00f7-0f58-4c33-bc78-c90c8923dc4e">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-01-30" />
      <value currency="USD" value-date="2024-01-30">4381362.00</value>
      <description>
        <narrative>Global Fund disbursement to RWA-C-MOHP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b53c8343-652d-4a96-8553-a8f978763fd0">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-04-16" />
      <value currency="USD" value-date="2024-04-16">5253977.79</value>
      <description>
        <narrative>Global Fund disbursement to RWA-C-MOHP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="03be5587-b7e3-4bbd-8b4b-bdc0537ab2cc">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-04-16" />
      <value currency="USD" value-date="2024-04-16">3890380.00</value>
      <description>
        <narrative>Global Fund disbursement to RWA-C-MOHP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="33f96294-879b-453b-b941-2527268b0408">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-04-16" />
      <value currency="USD" value-date="2024-04-16">245726.59</value>
      <description>
        <narrative>Global Fund disbursement to RWA-C-MOHP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="ec1ed1fd-7734-4fa3-b02b-6a4057f39a7c">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-05-28" />
      <value currency="USD" value-date="2024-05-28">144550.00</value>
      <description>
        <narrative>Global Fund disbursement to RWA-C-MOHP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="d14dc3c8-f844-4298-88c9-59c9b20755b0">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-07-02" />
      <value currency="USD" value-date="2024-07-02">12118620.00</value>
      <description>
        <narrative>Global Fund commitment to RWA-C-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="420ab315-9565-45f6-9825-60b294ce8143">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-07-04" />
      <value currency="USD" value-date="2024-07-04">7690280.00</value>
      <description>
        <narrative>Global Fund disbursement to RWA-C-MOHP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b41cd068-4b49-421c-a367-5cc21dfc81a7">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-07-17" />
      <value currency="USD" value-date="2024-07-17">-51091.50</value>
      <description>
        <narrative>Global Fund commitment to RWA-C-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e6ce1145-d3ac-4696-aee1-88756f35ce60">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-08-06" />
      <value currency="USD" value-date="2024-08-06">16480.00</value>
      <description>
        <narrative>Global Fund disbursement to RWA-C-MOHP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="07712c9b-ed84-4c79-a4e7-77e71c31771f">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-09-08" />
      <value currency="USD" value-date="2024-09-08">-2169.56</value>
      <description>
        <narrative>Global Fund commitment to RWA-C-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3bc59972-2cd7-49a0-a0e9-10623c773de0">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-10-15" />
      <value currency="USD" value-date="2024-10-15">4428340.00</value>
      <description>
        <narrative>Global Fund disbursement to RWA-C-MOHP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ba805135-f363-42c8-9160-3ae3daceb989">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-03-26" />
      <value currency="USD" value-date="2025-03-26">25258825.00</value>
      <description>
        <narrative>Global Fund commitment to RWA-C-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3c59f0a8-a627-4cbd-9971-8cd3ab09a230">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-04-01" />
      <value currency="USD" value-date="2025-04-01">11030834.00</value>
      <description>
        <narrative>Global Fund disbursement to RWA-C-MOHP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="23992bde-806f-4daf-927a-b9f738cb463f">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-05-13" />
      <value currency="USD" value-date="2025-05-13">4617980.00</value>
      <description>
        <narrative>Global Fund disbursement to RWA-C-MOHP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="662c31eb-0048-4582-aedf-95ef9ac9b57b">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-07-08" />
      <value currency="USD" value-date="2025-07-08">7896840.00</value>
      <description>
        <narrative>Global Fund disbursement to RWA-C-MOHP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1e2a20db-116b-43bc-be57-23d9c299be10">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-10-28" />
      <value currency="USD" value-date="2025-10-28">1713171.00</value>
      <description>
        <narrative>Global Fund disbursement to RWA-C-MOHP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4b7839c1-cea0-4b6f-9881-aeb0a0d6c118">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-11-10" />
      <value currency="USD" value-date="2025-11-10">-2782818.00</value>
      <description>
        <narrative>Global Fund commitment to RWA-C-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6e5d58d1-c6d6-4b59-8c80-32d19708962b">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-11-11" />
      <value currency="USD" value-date="2025-11-11">2782818.00</value>
      <description>
        <narrative>Funds returned to the Global Fund from RWA-C-MOHP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="RWA-C-MOHP01-EXP-20220630">
      <transaction-type code="4" />
      <transaction-date iso-date="2022-06-30" />
      <value currency="USD" value-date="2022-06-30">57589289.00</value>
      <description>
        <narrative>Expenditure reported by Ministry of Health of the Republic of Rwanda for RWA-C-MOHP01, Jul 2021 to Jun 2022.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </provider-org>
    </transaction>
    <transaction ref="RWA-C-MOHP01-EXP-20230630">
      <transaction-type code="4" />
      <transaction-date iso-date="2023-06-30" />
      <value currency="USD" value-date="2023-06-30">55643209.00</value>
      <description>
        <narrative>Expenditure reported by Ministry of Health of the Republic of Rwanda for RWA-C-MOHP01, Jul 2022 to Jun 2023.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </provider-org>
    </transaction>
    <transaction ref="RWA-C-MOHP01-EXP-20240630">
      <transaction-type code="4" />
      <transaction-date iso-date="2024-06-30" />
      <value currency="USD" value-date="2024-06-30">86220546.00</value>
      <description>
        <narrative>Expenditure reported by Ministry of Health of the Republic of Rwanda for RWA-C-MOHP01, Jul 2023 to Jun 2024.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </provider-org>
    </transaction>
    <transaction ref="RWA-C-MOHP01-EXP-20241231">
      <transaction-type code="4" />
      <transaction-date iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-12-31">8633815.00</value>
      <description>
        <narrative>Expenditure reported by Ministry of Health of the Republic of Rwanda for RWA-C-MOHP01, Jul 2024 to Dec 2024.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </provider-org>
    </transaction>
    <transaction ref="RWA-C-MOHP01-EXP-20250630">
      <transaction-type code="4" />
      <transaction-date iso-date="2025-06-30" />
      <value currency="USD" value-date="2025-06-30">14315546.00</value>
      <description>
        <narrative>Expenditure reported by Ministry of Health of the Republic of Rwanda for RWA-C-MOHP01, Jan 2025 to Jun 2025.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </provider-org>
    </transaction>
    <transaction ref="RWA-C-MOHP01-EXP-20251231">
      <transaction-type code="4" />
      <transaction-date iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-12-31">20682151.00</value>
      <description>
        <narrative>Expenditure reported by Ministry of Health of the Republic of Rwanda for RWA-C-MOHP01, Jan 2025 to Dec 2025.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/RWA-C-MOH" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-11" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/RWA/2020/TB_HIV/en/RWA-C_FundingRequest_1_en.zip" format="application/zip">
      <title>
        <narrative>2020 - Funding Request - Window 2b - TB/HIV - Rwanda - English</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR905-RWA-C.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2020-05-31" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of PSA plants installed with Global Fund investments and functional</narrative>
      </title>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of PSA plants installed with Global Fund investments and functional</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31">
          <comment>
            <narrative>Numerator: 29; Denominator: 52; Percentage: 55.77%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 37; Denominator: 52; Percentage: 71.15%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 39; Denominator: 52; Percentage: 75%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 60.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of health facilities with access to an IPC specialist</narrative>
      </title>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of health facilities with access to an IPC specialist</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - special.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31">
          <comment>
            <narrative>Numerator: 432; Denominator: 527; Percentage: 81.97%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 520.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 522.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 526.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 526.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate of RR TB and/or MDR-TB: Percentage of cases with RR and/or MDR-TB successfully treated</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Treatment success rate of RR TB and/or MDR-TB: Percentage of cases with RR and/or MDR-TB successfully treated</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31">
          <comment>
            <narrative>Numerator: 91; Denominator: 105; Percentage: 86.67%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 22; Denominator: 29; Percentage: 75.86%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 22; Denominator: 29; Percentage: 75.86%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 22; Denominator: 29; Percentage: 75.86%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Type of TB" value="XDR TB" />
          <comment>
            <narrative>Numerator: 0.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Type of TB" value="XDR TB" />
          <comment>
            <narrative>Numerator: 0.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 72; Denominator: 83; Percentage: 86.75%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 39; Denominator: 40; Percentage: 97.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 12; Denominator: 12; Percentage: 100%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2023-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 71; Denominator: 81; Percentage: 87.65%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 42; Denominator: 44; Percentage: 95.4%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 7; Denominator: 10; Percentage: 70%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 69; Denominator: 78; Percentage: 88.46%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Percentage: 91.3%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 12; Denominator: 12; Percentage: 100%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>PMTCT - Other 1: Percentage of exposed infants who are HIV-free by 24 months</narrative>
      </title>
      <description>
        <narrative>Module: PMTCT.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>PMTCT - Other 1: Percentage of exposed infants who are HIV-free by 24 months</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="98.26">
          <comment>
            <narrative>Numerator: 1528; Denominator: 1555.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2022-06-30" />
          <target value="95" />
          <actual value="98.6">
            <comment>
              <narrative>Numerator: 3609; Denominator: 3660.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2023-06-30" />
          <target value="95" />
          <actual value="99">
            <comment>
              <narrative>Numerator: 3595; Denominator: 3631.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2024-06-30" />
          <target value="95" />
          <actual value="99.1" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive women who received ART during pregnancy and/or labour and delivery</narrative>
      </title>
      <description>
        <narrative>Module: PMTCT.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive women who received ART during pregnancy and/or labour and delivery</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - special.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="96.9" />
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2022-06-30" />
          <target value="97" />
          <actual value="98" />
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2023-06-30" />
          <target value="97.2" />
          <actual value="99" />
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2024-06-30" />
          <target value="97.5" />
          <actual value="99.8" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of medical male circumcisions performed according to national standards</narrative>
      </title>
      <description>
        <narrative>Module: Prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of medical male circumcisions performed according to national standards</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="346157" />
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2022-06-30" />
          <target value="446641" />
          <actual value="319654" />
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2023-06-30" />
          <target value="482265" />
          <actual value="309822" />
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2024-06-30" />
          <target value="517094" />
          <actual value="350460" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>SD Other-1: Percent of health facilities offering Case based surveillance and index testing services</narrative>
      </title>
      <description>
        <narrative>Module: RSSH: Integrated service delivery and quality improvement.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>SD Other-1: Percent of health facilities offering Case based surveillance and index testing services</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2020" iso-date="2020-12-31" value="43.12">
          <comment>
            <narrative>Numerator: 235; Denominator: 545.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2022-06-30" />
          <target value="55.05">
            <comment>
              <narrative>Numerator: 300; Denominator: 545.</narrative>
            </comment>
          </target>
          <actual value="92.8">
            <comment>
              <narrative>Numerator: 512; Denominator: 552.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2023-06-30" />
          <target value="64.22">
            <comment>
              <narrative>Numerator: 350; Denominator: 545.</narrative>
            </comment>
          </target>
          <actual value="94.5">
            <comment>
              <narrative>Numerator: 552; Denominator: 584.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2024-06-30" />
          <target value="75.05">
            <comment>
              <narrative>Numerator: 409; Denominator: 545.</narrative>
            </comment>
          </target>
          <actual value="98.6">
            <comment>
              <narrative>Numerator: 560; Denominator: 568.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid tests at the time of diagnosis</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid tests at the time of diagnosis</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2020" iso-date="2020-12-31" value="77.05">
          <comment>
            <narrative>Numerator: 4298; Denominator: 5578.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2022-06-30" />
          <target value="79" />
          <actual value="49.8">
            <comment>
              <narrative>Numerator: 2759; Denominator: 5538.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2023-06-30" />
          <target value="83" />
          <actual value="69">
            <comment>
              <narrative>Numerator: 5949; Denominator: 8618.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2024-06-30" />
          <target value="85" />
          <actual value="68" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>TCP-Other 1: Proportion of TB cases notified in high-risk groups among all TB cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>TCP-Other 1: Proportion of TB cases notified in high-risk groups among all TB cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2020" iso-date="2020-12-31" value="50.37">
          <comment>
            <narrative>Numerator: 2860; Denominator: 5678.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2022-06-30" />
          <target value="55" />
          <actual value="50.4">
            <comment>
              <narrative>Numerator: 2793; Denominator: 5538.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2023-06-30" />
          <target value="58" />
          <actual value="62.2">
            <comment>
              <narrative>Numerator: 5852; Denominator: 9408.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2024-06-30" />
          <target value="60" />
          <actual value="57" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="86.53">
          <comment>
            <narrative>Numerator: 4946; Denominator: 5716.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31" value="79.18">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 4628; Denominator: 5845.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31" value="79.18">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 4628; Denominator: 5845.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31" value="7.24">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 423; Denominator: 5845.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31" value="7.24">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 423; Denominator: 5845.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31" value="7.24">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 423; Denominator: 5845.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31" value="17.18">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1004; Denominator: 5845.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31" value="17.18">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1004; Denominator: 5845.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31" value="17.18">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1004; Denominator: 5845.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31" value="59.42">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 3473; Denominator: 5845.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31" value="59.42">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 3473; Denominator: 5845.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31" value="59.42">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 3473; Denominator: 5845.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31" value="88.68">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 4059; Denominator: 4577.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31" value="88.68">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 4059; Denominator: 4577.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31" value="88.68">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 4059; Denominator: 4577.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31" value="77.88">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 887; Denominator: 1139.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31" value="77.88">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 887; Denominator: 1139.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31" value="77.88">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 887; Denominator: 1139.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2022-06-30" />
          <target value="87" />
          <actual value="88.8">
            <comment>
              <narrative>Numerator: 4877; Denominator: 5495.</narrative>
            </comment>
          </actual>
          <actual value="89.77">
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 4473; Denominator: 4983.</narrative>
            </comment>
          </actual>
          <actual value="93.33">
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 322; Denominator: 345.</narrative>
            </comment>
          </actual>
          <actual value="90.11">
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 1348; Denominator: 1496.</narrative>
            </comment>
          </actual>
          <actual value="89.95">
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 3447; Denominator: 3832.</narrative>
            </comment>
          </actual>
          <actual value="91.37">
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 4001; Denominator: 4379.</narrative>
            </comment>
          </actual>
          <actual value="83.67">
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 794; Denominator: 949.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2023-06-30" />
          <target value="88" />
          <actual value="86.7">
            <comment>
              <narrative>Numerator: 4791; Denominator: 5526.</narrative>
            </comment>
          </actual>
          <actual value="90.44">
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 246; Denominator: 272.</narrative>
            </comment>
          </actual>
          <actual value="86.36">
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 1311; Denominator: 1518.</narrative>
            </comment>
          </actual>
          <actual value="86.75">
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 4549; Denominator: 5244.</narrative>
            </comment>
          </actual>
          <actual value="89.05">
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 4204; Denominator: 4721.</narrative>
            </comment>
          </actual>
          <actual value="74.33">
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 585; Denominator: 787.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2024-06-30" />
          <target value="89" />
          <actual value="90.5">
            <comment>
              <narrative>Numerator: 8464; Denominator: 9351.</narrative>
            </comment>
          </actual>
          <actual value="88.04">
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 4474; Denominator: 5082.</narrative>
            </comment>
          </actual>
          <actual value="92.8">
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 322; Denominator: 347.</narrative>
            </comment>
          </actual>
          <actual value="88.68">
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 1348; Denominator: 1520.</narrative>
            </comment>
          </actual>
          <actual value="88.21">
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 3448; Denominator: 3909.</narrative>
            </comment>
          </actual>
          <actual value="89.97">
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 4002; Denominator: 4448.</narrative>
            </comment>
          </actual>
          <actual value="80.94">
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 794; Denominator: 981.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="97.37">
          <comment>
            <narrative>Numerator: 1186; Denominator: 1218.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2022-06-30" />
          <target value="95">
            <comment>
              <narrative>Numerator: 1064; Denominator: 1120.</narrative>
            </comment>
          </target>
          <actual value="94.8">
            <comment>
              <narrative>Numerator: 1083; Denominator: 1143.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2023-06-30" />
          <target value="95.02">
            <comment>
              <narrative>Numerator: 1031; Denominator: 1085.</narrative>
            </comment>
          </target>
          <actual value="93.5">
            <comment>
              <narrative>Numerator: 736; Denominator: 787.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2024-06-30" />
          <target value="95.04">
            <comment>
              <narrative>Numerator: 997; Denominator: 1049.</narrative>
            </comment>
          </target>
          <actual value="93" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2020" iso-date="2020-12-31">
          <comment>
            <narrative>Numerator: 201629; Denominator: 230833; Percentage: 87.35%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 195206; Denominator: 219528.5; Percentage: 88.92%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 195206; Denominator: 219528.5; Percentage: 88.92%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 195206; Denominator: 219528.5; Percentage: 88.92%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 6423; Denominator: 11304.5; Percentage: 56.82%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 6423; Denominator: 11304.5; Percentage: 56.82%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 126121; Denominator: 140132; Percentage: 90%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 126121; Denominator: 140132; Percentage: 90%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 126121; Denominator: 140132; Percentage: 90%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Gender | Age" value="Female | 15+" />
          <comment>
            <narrative>Numerator: 122833; Denominator: 134499; Percentage: 91.33%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Gender | Age" value="Female | 15+" />
          <comment>
            <narrative>Numerator: 122833; Denominator: 134499; Percentage: 91.33%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Gender | Age" value="Female | 15-19" />
          <comment>
            <narrative>Numerator: 3265; Denominator: 5408; Percentage: 60.37%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Gender | Age" value="Female | 15-19" />
          <comment>
            <narrative>Numerator: 3265; Denominator: 5408; Percentage: 60.37%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Gender | Age" value="Female | 15-19" />
          <comment>
            <narrative>Numerator: 3265; Denominator: 5408; Percentage: 60.37%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Gender | Age" value="Female | 15-24" />
          <comment>
            <narrative>Numerator: 10829; Denominator: 13019; Percentage: 83.18%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Gender | Age" value="Female | 15-24" />
          <comment>
            <narrative>Numerator: 10829; Denominator: 13019; Percentage: 83.18%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Gender | Age" value="Female | 15-24" />
          <comment>
            <narrative>Numerator: 10829; Denominator: 13019; Percentage: 83.18%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Gender | Age" value="Female | 20-24" />
          <comment>
            <narrative>Numerator: 7564; Denominator: 7610; Percentage: 99.4%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Gender | Age" value="Female | 20-24" />
          <comment>
            <narrative>Numerator: 7564; Denominator: 7610; Percentage: 99.4%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Gender | Age" value="Female | 20-24" />
          <comment>
            <narrative>Numerator: 7564; Denominator: 7610; Percentage: 99.4%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 75508; Denominator: 90700.5; Percentage: 83.25%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 75508; Denominator: 90700.5; Percentage: 83.25%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 75508; Denominator: 90700.5; Percentage: 83.25%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Gender | Age" value="Male | 15+" />
          <comment>
            <narrative>Numerator: 72373; Denominator: 85028; Percentage: 85.12%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Gender | Age" value="Male | 15+" />
          <comment>
            <narrative>Numerator: 72373; Denominator: 85028; Percentage: 85.12%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Gender | Age" value="Male | 15-19" />
          <comment>
            <narrative>Numerator: 2537; Denominator: 4003; Percentage: 63.38%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Gender | Age" value="Male | 15-19" />
          <comment>
            <narrative>Numerator: 2537; Denominator: 4003; Percentage: 63.38%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Gender | Age" value="Male | 15-19" />
          <comment>
            <narrative>Numerator: 2537; Denominator: 4003; Percentage: 63.38%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Gender | Age" value="Male | 15-24" />
          <comment>
            <narrative>Numerator: 5493; Denominator: 8236; Percentage: 66.69%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Gender | Age" value="Male | 15-24" />
          <comment>
            <narrative>Numerator: 5493; Denominator: 8236; Percentage: 66.69%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Gender | Age" value="Male | 15-24" />
          <comment>
            <narrative>Numerator: 5493; Denominator: 8236; Percentage: 66.69%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Gender | Age" value="Male | 20-24" />
          <comment>
            <narrative>Numerator: 2956; Denominator: 4233; Percentage: 69.83%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Gender | Age" value="Male | 20-24" />
          <comment>
            <narrative>Numerator: 2956; Denominator: 4233; Percentage: 69.83%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Gender | Age" value="Male | 20-24" />
          <comment>
            <narrative>Numerator: 2956; Denominator: 4233; Percentage: 69.83%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Duration of treatment" value="Newly initiating ART" />
          <comment>
            <narrative>Numerator: 11311; Denominator: 230833; Percentage: 4.9%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Duration of treatment" value="Newly initiating ART" />
          <comment>
            <narrative>Numerator: 11311; Denominator: 230833; Percentage: 4.9%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Duration of treatment" value="Newly initiating ART" />
          <comment>
            <narrative>Numerator: 11311; Denominator: 230833; Percentage: 4.9%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Target / Risk population group" value="Prisoners" />
          <comment>
            <narrative>Numerator: 3762.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Target / Risk population group" value="Prisoners" />
          <comment>
            <narrative>Numerator: 3762.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Target / Risk population group" value="Prisoners" />
          <comment>
            <narrative>Numerator: 3762.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 210591; Denominator: 232841; Percentage: 90.44%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 214074; Denominator: 227356; Percentage: 94.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 5311.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 208763.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 134297.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender | Age" value="Female | 15-19" />
            <comment>
              <narrative>Numerator: 3263.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender | Age" value="Female | 15-24" />
            <comment>
              <narrative>Numerator: 10695.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender | Age" value="Female | 20-24" />
            <comment>
              <narrative>Numerator: 7432.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 79777.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender | Age" value="Male | 15-19" />
            <comment>
              <narrative>Numerator: 2478.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender | Age" value="Male | 15-24" />
            <comment>
              <narrative>Numerator: 5573.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender | Age" value="Male | 20-24" />
            <comment>
              <narrative>Numerator: 3095.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Duration of treatment" value="Newly initiating ART" />
            <comment>
              <narrative>Numerator: 10398.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2023-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 213024; Denominator: 233741; Percentage: 91.14%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 218314; Denominator: 236518; Percentage: 92.3%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Percentage: 93.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Percentage: 58.22%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Percentage: 93.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender | Age" value="Female | 15+" />
            <comment>
              <narrative>Numerator: 135408; Denominator: 142523; Percentage: 95.01%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender | Age" value="Female | 15-19" />
            <comment>
              <narrative>Numerator: 3192; Denominator: 5036; Percentage: 63.38%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender | Age" value="Female | 15-24" />
            <comment>
              <narrative>Numerator: 10605; Denominator: 12493; Percentage: 84.89%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender | Age" value="Female | 20-24" />
            <comment>
              <narrative>Numerator: 7413; Denominator: 7457; Percentage: 99.41%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Percentage: 90.18%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender | Age" value="Male | 15+" />
            <comment>
              <narrative>Numerator: 77928; Denominator: 81450; Percentage: 95.68%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender | Age" value="Male | 15-19" />
            <comment>
              <narrative>Numerator: 2426; Denominator: 4208; Percentage: 57.65%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender | Age" value="Male | 15-24" />
            <comment>
              <narrative>Numerator: 5471; Denominator: 8548; Percentage: 64%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender | Age" value="Male | 20-24" />
            <comment>
              <narrative>Numerator: 3045; Denominator: 4340; Percentage: 70.16%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Duration of treatment" value="Newly initiating ART" />
            <comment>
              <narrative>Numerator: 10909; Denominator: 14506; Percentage: 75.2%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 216339; Denominator: 234585; Percentage: 92.22%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 222604; Denominator: 229759; Percentage: 96.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 218070; Denominator: 223774; Percentage: 97.45%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 140972; Denominator: 146436; Percentage: 96.27%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender | Age" value="Female | 15+" />
            <comment>
              <narrative>Numerator: 138615; Denominator: 143479; Percentage: 96.61%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender | Age" value="Female | 15-19" />
            <comment>
              <narrative>Numerator: 2964; Denominator: 3963; Percentage: 74.79%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender | Age" value="Female | 15-24" />
            <comment>
              <narrative>Numerator: 10435; Denominator: 11013; Percentage: 94.75%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender | Age" value="Female | 20-24" />
            <comment>
              <narrative>Numerator: 7471; Denominator: 7050; Percentage: 105.97%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 81632; Denominator: 83323; Percentage: 97.97%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender | Age" value="Male | 15+" />
            <comment>
              <narrative>Numerator: 79455; Denominator: 80297; Percentage: 98.95%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender | Age" value="Male | 15-19" />
            <comment>
              <narrative>Numerator: 2270; Denominator: 3146; Percentage: 72.16%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender | Age" value="Male | 15-24" />
            <comment>
              <narrative>Numerator: 5264; Denominator: 7448; Percentage: 70.68%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender | Age" value="Male | 20-24" />
            <comment>
              <narrative>Numerator: 2994; Denominator: 4302; Percentage: 69.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Duration of treatment" value="Newly initiating ART" />
            <comment>
              <narrative>Numerator: 11631; Denominator: 13296; Percentage: 87.48%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>TCS- Other 1: Percentage of people living with HIV on ART, who have suppressed viral load at 12 months ( VL &lt;1000 copies/ml)</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>TCS- Other 1: Percentage of people living with HIV on ART, who have suppressed viral load at 12 months ( VL &lt;1000 copies/ml)</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="93.35">
          <comment>
            <narrative>Numerator: 1066; Denominator: 1142.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2022-06-30" />
          <target value="93.3" />
          <actual value="97.7" />
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2023-06-30" />
          <target value="93.5" />
          <actual value="97" />
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2024-06-30" />
          <target value="93.5" />
          <actual value="93.7">
            <comment>
              <narrative>Numerator: 14081; Denominator: 15023.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>TCS- Other 2: Percentage of adults and children with HIV known to be on treatment 12 months after initiation of antiretroviral therapy</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>TCS- Other 2: Percentage of adults and children with HIV known to be on treatment 12 months after initiation of antiretroviral therapy</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2020" iso-date="2020-12-31" value="93.7">
          <comment>
            <narrative>Numerator: 1890; Denominator: 2017.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2022-06-30" />
          <target value="94" />
          <actual value="94.6" />
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2023-06-30" />
          <target value="94.2" />
          <actual value="94.7" />
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2024-06-30" />
          <target value="94.5" />
          <actual value="93.8">
            <comment>
              <narrative>Numerator: 5059; Denominator: 5392.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-11T11:05:58+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-RWA-C-MOH-2</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Supporting Rwanda Towards Reducing TB and HIV-related Morbidity and Mortality - Rwanda (01-Jul-2024-30-Jun-2027)</narrative>
    </title>
    <description type="1">
      <narrative>Rwanda, TB/HIV, Ministry of Health of the Republic of Rwanda</narrative>
    </description>
    <description type="2">
      <narrative>Goals: Reducing new HIV infections by 15% in 2027; Reduce HIV-related deaths by 2027 and decrease HIV morbidity; People infected and affected by HIV have the same opportunities as the general population; End the tuberculosis epidemic in Rwanda by 2035 which means 10 incident cases per 100 000 population or less per year (new and relapses); 65% reduction in TB deaths (compared with 2015); 33% reduction in TB incidence rate (compared with 2015); Reduction of TB-affected families facing catastrophic costs due to TB (to be determined (TBD) after the survey). Objectives: New HIV infections transmitted through sexual intercourse are reduced; Most at risk populations have access to combined HIV and Sexual Reproductive health prevention services; People access and use services to eliminate mother to child transmission of HIV, Syphilis and Hepatitis; Maintain blood  safety to enforce universal precautions for HIV, Hepatitis, and Syphilis; ART coverage and retention in care among all age categories of PLHIV is above 95%; Viral Load suppression among all PLHIV on ART is maintained above 95%; Reduced HIV morbidity and mortality related co-infections among PLHIV; Improved Psychosocial wellbeing for optimal and effective response to ART; Socioeconomic status for infected and affected people living with HIV is improved; Ensure social and legal protection of people infected and affected by HIV; Stigma and discrimination related to HIV is reduced; Social harm and violence among people infected and affected by HIV and key population are halted; Considering the patient pathway for tuberculosis; Targeted approaches for key drivers of TB epidemic among selected populations; Programmatic management, Multi-Sectoral collaboration &amp; engaging all care providers; Universal Health Coverage, social protection, human rights &amp; nutrition; Stable and quality assured supply of drugs, diagnostic and commodities.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="10" role="2" crs-channel-code="12001">
      <narrative>Ministry of Health of the Republic of Rwanda</narrative>
    </participating-org>
    <participating-org type="10" role="4" crs-channel-code="12001">
      <narrative>Ministry of Health of the Republic of Rwanda</narrative>
    </participating-org>
    <other-identifier ref="RWA-C-MOHP02" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="2" />
    <activity-date type="1" iso-date="2024-07-01" />
    <activity-date type="2" iso-date="2024-07-01" />
    <activity-date type="3" iso-date="2027-06-30" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Musoke Sempala</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>musoke.sempala@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="RW" percentage="100">
      <narrative>Rwanda</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12110" percentage="100">
      <narrative>Multicomponent</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="2096020e-7c83-492e-bcab-d280cb1e85bf" percentage="100">
        <description>
          <narrative>Multicomponent -&gt; Payment for results -&gt; Payment for results</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2024-01-01" />
      <period-end iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-01-01">40139705.00</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2025-01-01" />
      <period-end iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-01-01">36374988.00</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2026-01-01" />
      <period-end iso-date="2026-12-31" />
      <value currency="USD" value-date="2026-01-01">37311654.00</value>
    </budget>
    <capital-spend percentage="0" />
    <transaction ref="215dc397-aab1-4520-b7c3-fed0e4553953">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-07-09" />
      <value currency="USD" value-date="2024-07-09">57232320.00</value>
      <description>
        <narrative>Global Fund commitment to RWA-C-MOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f666e322-77c6-4765-9ebd-dd2b7f27c883">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-07-11" />
      <value currency="USD" value-date="2024-07-11">7429728.00</value>
      <description>
        <narrative>Global Fund disbursement to RWA-C-MOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="60d6d239-a158-4f1c-80ce-36abf0aea727">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-10-03" />
      <value currency="USD" value-date="2024-10-03">19839214.00</value>
      <description>
        <narrative>Global Fund disbursement to RWA-C-MOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="cee7f7f8-696d-4609-899b-297d20d3905b">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-01-14" />
      <value currency="USD" value-date="2025-01-14">8210835.00</value>
      <description>
        <narrative>Global Fund disbursement to RWA-C-MOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="62d87673-0301-4702-b2ab-b52bd89aa69b">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-04-15" />
      <value currency="USD" value-date="2025-04-15">5038926.00</value>
      <description>
        <narrative>Global Fund disbursement to RWA-C-MOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4701cedd-ca3f-4bee-ab79-6b439b79a226">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-07-01" />
      <value currency="USD" value-date="2025-07-01">11334917.00</value>
      <description>
        <narrative>Global Fund disbursement to RWA-C-MOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a3854211-9a02-4646-b6c9-e773764151da">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-09-09" />
      <value currency="USD" value-date="2025-09-09">550000.00</value>
      <description>
        <narrative>Global Fund disbursement to RWA-C-MOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="db3cd31c-8301-4523-90fa-3b1bf3c10dca">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-10-28" />
      <value currency="USD" value-date="2025-10-28">1506424.00</value>
      <description>
        <narrative>Global Fund disbursement to RWA-C-MOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="5d5a71fc-19bf-494c-8367-18dc81cd1a20">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-11-10" />
      <value currency="USD" value-date="2025-11-10">2782818.00</value>
      <description>
        <narrative>Global Fund commitment to RWA-C-MOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4771078a-9497-40a1-b23e-17d45ccce541">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-11-11" />
      <value currency="USD" value-date="2025-11-11">2782818.00</value>
      <description>
        <narrative>Global Fund disbursement to RWA-C-MOHP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="2cee756a-0902-4773-955f-d82c200b02e5">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-12-19" />
      <value currency="USD" value-date="2025-12-19">-3322276.00</value>
      <description>
        <narrative>Global Fund commitment to RWA-C-MOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a9fed9f1-060e-4fab-96c2-6c6e00999eaa">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-12-19" />
      <value currency="USD" value-date="2025-12-19">34500467.00</value>
      <description>
        <narrative>Global Fund commitment to RWA-C-MOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1b5704f7-ad1d-4873-9941-454a23d4b643">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-01-13" />
      <value currency="USD" value-date="2026-01-13">1550000.00</value>
      <description>
        <narrative>Global Fund disbursement to RWA-C-MOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ee6363bb-703d-4b9b-a640-c9ea899329a2">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-01-13" />
      <value currency="USD" value-date="2026-01-13">17583824.00</value>
      <description>
        <narrative>Global Fund disbursement to RWA-C-MOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="53d75d7a-ba3b-4f1a-961b-9eeb3d2f8c3d">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-04-15" />
      <value currency="USD" value-date="2026-04-15">1550000.00</value>
      <description>
        <narrative>Global Fund disbursement to RWA-C-MOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="786409f3-df4a-40ef-871b-832fd6329898">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-04-15" />
      <value currency="USD" value-date="2026-04-15">1983826.00</value>
      <description>
        <narrative>Global Fund disbursement to RWA-C-MOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="132ec8f9-c99f-411d-bf9e-b124687b6b64">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-06-05" />
      <value currency="USD" value-date="2026-06-05">144000.00</value>
      <description>
        <narrative>Global Fund commitment to RWA-C-MOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ea652070-d7ba-4acc-af66-198cdfd4c012">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-07-07" />
      <value currency="USD" value-date="2026-07-07">7830199.00</value>
      <description>
        <narrative>Global Fund disbursement to RWA-C-MOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c0e29a61-54be-493c-b06a-ac43e40eb5b0">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-10-06" />
      <value currency="USD" value-date="2026-10-06">4002618.00</value>
      <description>
        <narrative>Global Fund disbursement to RWA-C-MOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8da371b2-edf8-46cd-ab1d-86707b004c9c">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-11-03" />
      <value currency="USD" value-date="2026-11-03">90000.00</value>
      <description>
        <narrative>Global Fund disbursement to RWA-C-MOHP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="RWA-C-MOHP02-EXP-20250630">
      <transaction-type code="4" />
      <transaction-date iso-date="2025-06-30" />
      <value currency="USD" value-date="2025-06-30">44103925.00</value>
      <description>
        <narrative>Expenditure reported by Ministry of Health of the Republic of Rwanda for RWA-C-MOHP02, Jul 2024 to Jun 2025.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health of the Republic of Rwanda</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/RWA-C-MOH" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-11" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/RWA/2023/TB_HIV/en/RWA-C_FundingRequest_1_en.zip" format="application/zip">
      <title>
        <narrative>2023 - Funding Request - Window 3 - TB/HIV - Rwanda - English</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR1420-RWA-C.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2023-08-21" />
    </document-link>
    <conditions attached="1">
      <condition type="1">
        <narrative>1 - Personal Data (1) Principles. The Principal Recipient, acknowledges that Program Activities are expected to respect the following principles and rights (“Data Protection Principles”): (a) Information that could be used to identify a natural person (“Personal Data”) will be: (i) processed lawfully, fairly and transparently; (ii) collected for specified, explicit and legitimate purposes and not further processed in a manner not compatible with those purposes;  (iii) adequate, relevant and limited to what is necessary for the purposes for which they are processed; (iv) accurate and, where necessary, kept up to date; (v) kept in a form which permits identification of the individuals for no longer than is necessary for the purposes for which the Personal Data is processed; and (vi) processed in a manner that ensures appropriate security of the Personal Data; and (b) Natural persons are afforded, where relevant, the right to information about Personal Data that is processed; the right to access and rectify or erase Personal Data; the right to data portability; the right to confidentiality of electronic communications; and the right to object to processing. (2) Limitations. Where collection and processing of Personal Data is required in order to implement Program Activities, whether by the Principal Recipient, a Sub-recipient, or Supplier, the Principal Recipient should respect the Data Protection Principles: (a) to the extent that doing so does not violate or conflict with applicable law and/or policy; and (b) subject to the Principal Recipient balancing the Data Protection Principles with other fundamental rights in accordance with the principle of proportionality, taking into account the risks to the rights and freedoms of natural persons.</narrative>
      </condition>
      <condition type="1">
        <narrative>2 - Right of Access With respect to Section 7.6 (Right of Access) of the Global Fund Grant Regulations (as amended from time to time), (1) the Global Fund may collect or seek to collect data, and it is possible that such data may contain Personal Data, and (2), prior to collection and at all times thereafter, the Principal Recipient shall take all necessary actions to ensure that the transfer of such information to the Global Fund does not violate any applicable law or regulation.</narrative>
      </condition>
      <condition type="1">
        <narrative>3 - (1)In accordance with the Global Fund’s Sustainability, Transition and Co-financing Policy (GF/B35/04) (the “STC Policy”), the commitment and disbursement of USD 18,724,381 (the “Co-Financing Incentive”), is subject to the Global Fund’s satisfaction of the Grantee’s compliance with the requirements listed at 6.3(1)(a) and 6.3(1)(b) below (“Co-Financing Requirements”). The Principal Recipient acknowledges and agrees that the Global Fund may reduce Grant Funds during the current or any subsequent Implementation Period in the event the Grantee fails to: (a) progressively increase government expenditure on health to meet national universal health coverage goals; and/or (b) maintain domestic funding of Global Fund-supported programs, with a focus on progressively absorbing the key costs of national disease plans, as identified in consultation with the Global Fund. (2) In order to satisfy the Co-Financing Requirements, the Grantee shall, as set out in the letter of government co-financing commitment to Global Fund-supported national responses dated 12 March 2024 (the “Commitment Letter”), unless otherwise agreed in writing by the Global Fund: (a) fulfil a total minimum co-financing commitment of USD 283,591,304 from 2025-2027 (inclusive), comprising investments in: i. HIV of USD 76,385,201; ii. TB of USD 8,680,256; iii. RSSH of USD 118,220,833 (b) fulfil the programmatic commitments as stipulated in Section 1.3 of the Commitment Letter; and (c) provide to the Global Fund, by no later than 31 August of each year of the Implementation Period and the year following the end of the Implementation Period, evidence supporting achievement of the Co-Financing Requirements, including: i. the approved annual budget for HIV/TB/RSSH for the upcoming year; and ii. the total expenditure for HIV/TB/RSSH in the previous fiscal year.</narrative>
      </condition>
      <condition type="2">
        <narrative>4 - The Program budget may be funded in part by Grant Funds disbursed under a previous Grant Agreement, which the Global Fund has approved to be used for the Program under the current Grant Agreement (“Previously Disbursed Grant Funds”), as well as additional Grant Funds up to the amount set forth in Section 3.6. hereof. Accordingly, the Global Fund may reduce the amount of Grant Funds set forth in Section 3.6. hereof by the amount of any Previously Disbursed Grant Funds. Previously Disbursed Grant Funds shall be governed by the terms of this Grant Agreement.</narrative>
      </condition>
    </conditions>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative>
      </title>
      <description>
        <narrative>Module: Drug-resistant (DR)-TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 38; Denominator: 40; Percentage: 95%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 38; Denominator: 40; Percentage: 95%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 0.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 0.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 13; Denominator: 13; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 13; Denominator: 13; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Treatment regimen" value="Longer individualized" />
          <comment>
            <narrative>Numerator: 15; Denominator: 16; Percentage: 93.75%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Treatment regimen" value="Longer individualized" />
          <comment>
            <narrative>Numerator: 15; Denominator: 16; Percentage: 93.75%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 26; Denominator: 27; Percentage: 96.3%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 26; Denominator: 27; Percentage: 96.3%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 27; Denominator: 28; Percentage: 96.43%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 27; Denominator: 28; Percentage: 96.43%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 12; Denominator: 12; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 12; Denominator: 12; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Provider type" value="Public" />
          <comment>
            <narrative>Numerator: 39; Denominator: 40; Percentage: 97.5%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Provider type" value="Public" />
          <comment>
            <narrative>Numerator: 39; Denominator: 40; Percentage: 97.5%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Treatment regimen" value="Shorter 6-9 month" />
          <comment>
            <narrative>Numerator: 24; Denominator: 24; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Treatment regimen" value="Shorter 6-9 month" />
          <comment>
            <narrative>Numerator: 24; Denominator: 24; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="HIV status" value="Unknown" />
          <comment>
            <narrative>Numerator: 0.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="HIV status" value="Unknown" />
          <comment>
            <narrative>Numerator: 0.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 42; Denominator: 44; Percentage: 95.45%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 92.5%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 77; Denominator: 90; Percentage: 85.56%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 76; Denominator: 88; Percentage: 86.36%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 1; Denominator: 2; Percentage: 50%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 22; Denominator: 24; Percentage: 91.67%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Longer individualized" />
            <comment>
              <narrative>Numerator: 2.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 55; Denominator: 66; Percentage: 83.33%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 65; Denominator: 73; Percentage: 89.04%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 12; Denominator: 17; Percentage: 70.59%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Provider type" value="Public" />
            <comment>
              <narrative>Numerator: 77; Denominator: 90; Percentage: 85.56%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Shorter 6-9 month" />
            <comment>
              <narrative>Numerator: 75.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Unknown" />
            <comment>
              <narrative>Numerator: 0; Denominator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 93%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 44; Denominator: 48; Percentage: 91.67%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 43; Denominator: 45; Percentage: 95.56%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 1; Denominator: 3; Percentage: 33.33%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 7; Denominator: 7; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Longer individualized" />
            <comment>
              <narrative>Numerator: 42.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 37; Denominator: 41; Percentage: 90.24%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 33; Denominator: 34; Percentage: 97.06%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 11; Denominator: 14; Percentage: 78.57%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Provider type" value="Public" />
            <comment>
              <narrative>Numerator: 44; Denominator: 48; Percentage: 91.67%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Shorter 6-9 month" />
            <comment>
              <narrative>Numerator: 41.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Unknown" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2027-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 93%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of pregnant women who know their HIV status</narrative>
      </title>
      <description>
        <narrative>Module: Elimination of vertical transmission of HIV, syphilis and hepatitis B.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of pregnant women who know their HIV status</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - special.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="100">
          <comment>
            <narrative>Numerator: 365759; Denominator: 365759.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2025-06-30" />
          <target value="100" />
          <actual value="99.54">
            <comment>
              <narrative>Numerator: 362995; Denominator: 364665.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target value="100" />
          <actual value="96.47">
            <comment>
              <narrative>Numerator: 349427; Denominator: 362208.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2027-06-30" />
          <target value="100" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>VT-2 other 1: Percentage of exposed infants who are HIV Free by 24 months of age.</narrative>
      </title>
      <description>
        <narrative>Module: Elimination of vertical transmission of HIV, syphilis and hepatitis B.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>VT-2 other 1: Percentage of exposed infants who are HIV Free by 24 months of age.</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="98.66" />
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2025-06-30" />
          <target value="98.7" />
          <actual value="98.9">
            <comment>
              <narrative>Numerator: 98.9; Denominator: 100.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target value="98.8" />
          <actual value="99.7">
            <comment>
              <narrative>Numerator: 99.7; Denominator: 100.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2027-06-30" />
          <target value="98.9" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>TBDT-1 other 4 : Proportion of TB cases notified in high risk grougs among all TB cases.</narrative>
      </title>
      <description>
        <narrative>Module: Key and vulnerable populations (KVP) - TB/DR-TB.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>TBDT-1 other 4 : Proportion of TB cases notified in high risk grougs among all TB cases.</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="62.14">
          <comment>
            <narrative>Numerator: 5852; Denominator: 9417.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2025-06-30" />
          <target value="54" />
          <actual value="74.69">
            <comment>
              <narrative>Numerator: 6122; Denominator: 8196.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target value="55" />
          <actual value="73.79">
            <comment>
              <narrative>Numerator: 6105; Denominator: 8274.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2027-06-30" />
          <target value="55" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of sex workers who received any PrEP product at least once during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for sex workers, their clients and other sexual partners.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of sex workers who received any PrEP product at least once during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="8550" />
        <baseline year="2023" iso-date="2023-12-31" value="8550">
          <dimension name="Gender" value="Female" />
        </baseline>
        <baseline year="2023" iso-date="2023-12-31" value="8550">
          <dimension name="Gender" value="Female" />
        </baseline>
        <baseline year="2023" iso-date="2023-12-31" value="8550">
          <dimension name="PrEP product" value="Oral PrEP" />
        </baseline>
        <baseline year="2023" iso-date="2023-12-31" value="8550">
          <dimension name="PrEP product" value="Oral PrEP" />
        </baseline>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2025-06-30" />
          <target value="10000" />
          <actual value="11862" />
          <actual value="11862">
            <dimension name="Gender" value="Female" />
          </actual>
          <actual value="11862">
            <dimension name="PrEP product" value="Oral PrEP" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target value="12000" />
          <actual value="13421" />
          <actual value="13421">
            <dimension name="Gender" value="Female" />
          </actual>
          <actual value="13421">
            <dimension name="PrEP product" value="Oral PrEP" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2027-06-30" />
          <target value="14000" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>RSSH/PP HRH Other-6 : Number of Medical students enrolled in HRH program per year</narrative>
      </title>
      <description>
        <narrative>Module: RSSH/PP: Human resources for health (HRH) and quality of care.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>RSSH/PP HRH Other-6 : Number of Medical students enrolled in HRH program per year</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="453" />
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2025-06-30" />
          <target value="509" />
          <actual value="952" />
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target value="515" />
          <actual value="580" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2027-06-30" />
          <target value="515" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of laboratories successfully participating in external quality assurance (EQA) or proficiency testing (PT) schemes</narrative>
      </title>
      <description>
        <narrative>Module: RSSH/PP: Laboratory systems (including national and peripheral).</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of laboratories successfully participating in external quality assurance (EQA) or proficiency testing (PT) schemes</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="63" />
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2025-06-30" />
          <target value="73" />
          <actual value="90.76">
            <comment>
              <narrative>Numerator: 707; Denominator: 779.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target value="75" />
          <actual value="95">
            <comment>
              <narrative>Numerator: 95; Denominator: 100.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2027-06-30" />
          <target value="78" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>RSSH Other-7: % HFs with &lt; 5% of medical products stock-outs</narrative>
      </title>
      <description>
        <narrative>Module: RSSH: Health products management systems.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>RSSH Other-7: % HFs with &lt; 5% of medical products stock-outs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31">
          <comment>
            <narrative>Numerator: 0.88.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 90%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 90; Denominator: 100; Percentage: 90%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 92%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 93.8; Denominator: 100; Percentage: 93.8%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2027-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 95%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 5183; Denominator: 5455; Percentage: 95.01%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 5183; Denominator: 5455; Percentage: 95.01%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 272; Denominator: 5455; Percentage: 4.99%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 272; Denominator: 5455; Percentage: 4.99%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 3976; Denominator: 5455; Percentage: 72.89%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 3976; Denominator: 5455; Percentage: 72.89%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1500; Denominator: 5455; Percentage: 27.5%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1500; Denominator: 5455; Percentage: 27.5%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 3955; Denominator: 5455; Percentage: 72.5%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 3955; Denominator: 5455; Percentage: 72.5%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 4672; Denominator: 5455; Percentage: 85.65%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 4672; Denominator: 5455; Percentage: 85.65%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 777; Denominator: 5455; Percentage: 14.24%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 777; Denominator: 5455; Percentage: 14.24%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="HIV status" value="Unknown" />
          <comment>
            <narrative>Numerator: 6; Denominator: 5455; Percentage: 0.11%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="HIV status" value="Unknown" />
          <comment>
            <narrative>Numerator: 6; Denominator: 5455; Percentage: 0.11%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 9220.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 6184.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 8196.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 7037.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 1159.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 5850.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 2365.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 5831.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 7097.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 1096.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Unknown" />
            <comment>
              <narrative>Numerator: 3.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 5961.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 8108.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 7134.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 1140.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 5925.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 2324.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 5950.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 6978.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 1294.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Unknown" />
            <comment>
              <narrative>Numerator: 2.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2027-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 5723.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="69.67">
          <comment>
            <narrative>Numerator: 6561; Denominator: 9417.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2025-06-30" />
          <target value="70" />
          <actual value="68.25">
            <comment>
              <narrative>Numerator: 5594; Denominator: 8196.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target value="75" />
          <actual value="72.03">
            <comment>
              <narrative>Numerator: 5840; Denominator: 8108.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2027-06-30" />
          <target value="80" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2021" iso-date="2021-12-31" value="88.04">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 4474; Denominator: 5082.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31" value="88.04">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 4474; Denominator: 5082.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31" value="92.8">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 322; Denominator: 347.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31" value="92.8">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 322; Denominator: 347.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31" value="88.68">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1348; Denominator: 1520.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31" value="88.68">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1348; Denominator: 1520.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31" value="88.21">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 3448; Denominator: 3909.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31" value="88.21">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 3448; Denominator: 3909.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31" value="89.97">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 4002; Denominator: 4448.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31" value="89.97">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 4002; Denominator: 4448.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31" value="80.94">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 794; Denominator: 981.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31" value="80.94">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 794; Denominator: 981.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="86.7">
          <comment>
            <narrative>Numerator: 4791; Denominator: 5526.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2025-06-30" />
          <target value="89.5" />
          <actual value="90.28">
            <comment>
              <narrative>Numerator: 7494; Denominator: 8301.</narrative>
            </comment>
          </actual>
          <actual value="89.88">
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 6780; Denominator: 7543.</narrative>
            </comment>
          </actual>
          <actual value="94.2">
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 714; Denominator: 758.</narrative>
            </comment>
          </actual>
          <actual value="88.86">
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 1954; Denominator: 2199.</narrative>
            </comment>
          </actual>
          <actual value="90.79">
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 5540; Denominator: 6102.</narrative>
            </comment>
          </actual>
          <actual value="91.59">
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 6587; Denominator: 7192.</narrative>
            </comment>
          </actual>
          <actual value="81.79">
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 907; Denominator: 1109.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target value="90" />
          <actual value="90.73">
            <comment>
              <narrative>Numerator: 7282; Denominator: 8026.</narrative>
            </comment>
          </actual>
          <actual value="89.44">
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 6260; Denominator: 6999.</narrative>
            </comment>
          </actual>
          <actual value="97.33">
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 1128; Denominator: 1159.</narrative>
            </comment>
          </actual>
          <actual value="91.49">
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 2160; Denominator: 2361.</narrative>
            </comment>
          </actual>
          <actual value="90.18">
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 5228; Denominator: 5797.</narrative>
            </comment>
          </actual>
          <actual value="91.91">
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 6501; Denominator: 7073.</narrative>
            </comment>
          </actual>
          <actual value="81.75">
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 887; Denominator: 1085.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2027-06-30" />
          <target value="90" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>TBP-1 other 5: TPT coverage among contacts ≥ 5 years</narrative>
      </title>
      <description>
        <narrative>Module: TB/DR-TB Prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>TBP-1 other 5: TPT coverage among contacts ≥ 5 years</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="81.81">
          <comment>
            <narrative>Numerator: 1695; Denominator: 2072.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2025-06-30" />
          <target value="83" />
          <actual value="91.87">
            <comment>
              <narrative>Numerator: 1389; Denominator: 1512.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target value="84" />
          <actual value="95.39">
            <comment>
              <narrative>Numerator: 1220; Denominator: 1279.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2027-06-30" />
          <target value="85" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 914; Denominator: 961; Percentage: 95.11%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 914; Denominator: 961; Percentage: 95.11%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Age" value="5-14" />
          <comment>
            <narrative>Numerator: 10; Denominator: 10; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Age" value="5-14" />
          <comment>
            <narrative>Numerator: 10; Denominator: 10; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 8; Denominator: 10; Percentage: 80%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 8; Denominator: 10; Percentage: 80%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 321; Denominator: 339; Percentage: 94.69%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 321; Denominator: 339; Percentage: 94.69%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 611; Denominator: 642; Percentage: 95.17%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 611; Denominator: 642; Percentage: 95.17%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 733; Denominator: 787; Percentage: 93.14%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 95.5%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1053; Denominator: 1108; Percentage: 95.04%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1033; Denominator: 1085; Percentage: 95.21%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="5-14" />
            <comment>
              <narrative>Numerator: 10; Denominator: 11; Percentage: 90.91%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 10; Denominator: 12; Percentage: 83.33%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 353; Denominator: 370; Percentage: 95.41%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 701; Denominator: 739; Percentage: 94.86%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 96%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1019; Denominator: 1072; Percentage: 95.06%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 991; Denominator: 1044; Percentage: 94.92%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="5-14" />
            <comment>
              <narrative>Numerator: 12; Denominator: 12; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 16.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 349; Denominator: 368; Percentage: 94.84%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 670; Denominator: 704; Percentage: 95.17%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2027-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 96%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of adults (15 and above) on ART among all adults living with HIV at the end of the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of adults (15 and above) on ART among all adults living with HIV at the end of the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="93.24">
          <comment>
            <narrative>Numerator: 213298; Denominator: 228772.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31" value="96.76">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 137990; Denominator: 142610.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31" value="96.76">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 137990; Denominator: 142610.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31" value="96.48">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 80324; Denominator: 83252.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31" value="96.48">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 80324; Denominator: 83252.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2025-06-30" />
          <target value="93.81">
            <comment>
              <narrative>Numerator: 212748; Denominator: 226791.</narrative>
            </comment>
          </target>
          <actual value="97.48">
            <comment>
              <narrative>Numerator: 224941; Denominator: 230765.</narrative>
            </comment>
          </actual>
          <actual value="98.54">
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 143881; Denominator: 146012.</narrative>
            </comment>
          </actual>
          <actual value="96.51">
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 81060; Denominator: 83991.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target value="94.74">
            <comment>
              <narrative>Numerator: 213726; Denominator: 225604.</narrative>
            </comment>
          </target>
          <actual value="99.57">
            <comment>
              <narrative>Numerator: 226283; Denominator: 227268.</narrative>
            </comment>
          </actual>
          <actual value="100.02">
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 144813; Denominator: 144777.</narrative>
            </comment>
          </actual>
          <actual value="98.76">
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 81470; Denominator: 82492.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2027-06-30" />
          <target value="95.69">
            <comment>
              <narrative>Numerator: 214510; Denominator: 224167.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of children (under 15) on ART among all children living with HIV at the end of the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of children (under 15) on ART among all children living with HIV at the end of the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="58.22">
          <comment>
            <narrative>Numerator: 4971; Denominator: 8539.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31" value="79.4">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 2452; Denominator: 3088.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31" value="79.4">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 2452; Denominator: 3088.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31" value="79.11">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 2499; Denominator: 3159.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31" value="79.11">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 2499; Denominator: 3159.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2025-06-30" />
          <target value="67.99">
            <comment>
              <narrative>Numerator: 4986; Denominator: 7333.</narrative>
            </comment>
          </target>
          <actual value="75.07">
            <comment>
              <narrative>Numerator: 4334; Denominator: 5773.</narrative>
            </comment>
          </actual>
          <actual value="78.16">
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 2240; Denominator: 2866.</narrative>
            </comment>
          </actual>
          <actual value="72.03">
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 2094; Denominator: 2907.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target value="69.72">
            <comment>
              <narrative>Numerator: 4762; Denominator: 6830.</narrative>
            </comment>
          </target>
          <actual value="58.89">
            <comment>
              <narrative>Numerator: 4061; Denominator: 6896.</narrative>
            </comment>
          </actual>
          <actual value="60.8">
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 2085; Denominator: 3429.</narrative>
            </comment>
          </actual>
          <actual value="56.99">
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1976; Denominator: 3467.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2027-06-30" />
          <target value="70.83">
            <comment>
              <narrative>Numerator: 4549; Denominator: 6422.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people living with HIV and currently on antiretroviral therapy who are receiving multi month dispensing of antiretroviral medicine</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people living with HIV and currently on antiretroviral therapy who are receiving multi month dispensing of antiretroviral medicine</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="79.18">
          <comment>
            <narrative>Numerator: 172866; Denominator: 218314.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2025-06-30" />
          <target value="82" />
          <actual value="89.82">
            <comment>
              <narrative>Numerator: 205938; Denominator: 229275.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target value="85" />
          <actual value="90.81">
            <comment>
              <narrative>Numerator: 209179; Denominator: 230344.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2027-06-30" />
          <target value="89" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people living with HIV and on ART with viral load test result</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people living with HIV and on ART with viral load test result</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="99.4">
          <comment>
            <narrative>Numerator: 180103; Denominator: 181190.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2025-06-30" />
          <target value="99.4" />
          <actual value="88.01">
            <comment>
              <narrative>Numerator: 219011; Denominator: 248851.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target value="99.4" />
          <actual value="90.06">
            <comment>
              <narrative>Numerator: 210675; Denominator: 233918.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2027-06-30" />
          <target value="99.4" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="92.3">
          <comment>
            <narrative>Numerator: 218314; Denominator: 236518.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2025-06-30" />
          <target value="93">
            <comment>
              <narrative>Numerator: 217734; Denominator: 234124.</narrative>
            </comment>
          </target>
          <actual value="96.93">
            <comment>
              <narrative>Numerator: 229275; Denominator: 236538.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target value="94">
            <comment>
              <narrative>Numerator: 218488; Denominator: 232434.</narrative>
            </comment>
          </target>
          <actual value="98.37">
            <comment>
              <narrative>Numerator: 230344; Denominator: 234164.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2027-06-30" />
          <target value="95">
            <comment>
              <narrative>Numerator: 219059; Denominator: 230589.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of pregnant women living with HIV who received antiretroviral medicine to reduce the risk of vertical transmission of HIV</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of pregnant women living with HIV who received antiretroviral medicine to reduce the risk of vertical transmission of HIV</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - special.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="99" />
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2025-06-30" />
          <target value="99" />
          <actual value="99.9">
            <comment>
              <narrative>Numerator: 99.9; Denominator: 100.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target value="99" />
          <actual value="98.02">
            <comment>
              <narrative>Numerator: 4846; Denominator: 4944.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2027-06-30" />
          <target value="99" />
        </period>
      </indicator>
    </result>
  </iati-activity>
</iati-activities>